Link To Us Link To Us

Bookmark Us Bookmark Us

Supplier Login Supplier Login

Linscott's Directory of Immunological & Biological Reagents
CAYMAN CHEMICAL COMPANY
 (http://www.caymanchem.com)

CAYMAN CHEMICAL COMPANY

1180 East Ellsworth Road

Ann Arbor MI 48108

Phone: (734) 971-3335

Phone: (800) 364-9897 (USA & Canada only)

Fax: (734) 971-3640

Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com

Website: http://www.caymanchem.com

 
 
CAYMAN CHEMICAL COMPANY Products - Page 194 of 734
Page 194 of 734
Records 4,826 - 4,850 of 18,348
Name Description Size Catalog #
AFP 07 (free acid) A 7,7-difluoroprostacyclin derivative that acts as a selective and highly potent agonist for the IP receptor (Ki = 0.561 nM); shows weaker affinity for EP receptors, with Ki values of > 100 nM for EP1-3 and > 10 nM for EP4 5 mg 13626-5
AFP 07 (free acid) A 7,7-difluoroprostacyclin derivative that acts as a selective and highly potent agonist for the IP receptor (Ki = 0.561 nM); shows weaker affinity for EP receptors, with Ki values of > 100 nM for EP1-3 and > 10 nM for EP4 500 µg 13626-500
AG-041R A potent CCKB/gastrin receptor antagonist that exhibits selective binding for CCKB compared to CCKA; exhibits synergistic inhibitory effects on the cell viability of human gastric cancer cells when administered in combination with the selective COX-2 inhibitor NS-398 1 mg 10010129-1
AG-041R A potent CCKB/gastrin receptor antagonist that exhibits selective binding for CCKB compared to CCKA; exhibits synergistic inhibitory effects on the cell viability of human gastric cancer cells when administered in combination with the selective COX-2 inhibitor NS-398 10 mg 10010129-10
AG-041R A potent CCKB/gastrin receptor antagonist that exhibits selective binding for CCKB compared to CCKA; exhibits synergistic inhibitory effects on the cell viability of human gastric cancer cells when administered in combination with the selective COX-2 inhibitor NS-398 5 mg 10010129-5
AG-041R A potent CCKB/gastrin receptor antagonist that exhibits selective binding for CCKB compared to CCKA; exhibits synergistic inhibitory effects on the cell viability of human gastric cancer cells when administered in combination with the selective COX-2 inhibitor NS-398 50 mg 10010129-50
AG-1024 A selective inhibitor of IGF-1R that inhibits insulin-stimulated cellular proliferation and IGF-1R autophosphorylation with IC50 values of 0.4 and 7 µM, respectively; inhibits proliferation of human breast cancer MCF-7 cells (10 nM) and human prostate cancer DU145 cells (IC50 = 2.5 µM) 1 mg 14833-1
AG-1024 A selective inhibitor of IGF-1R that inhibits insulin-stimulated cellular proliferation and IGF-1R autophosphorylation with IC50 values of 0.4 and 7 µM, respectively; inhibits proliferation of human breast cancer MCF-7 cells (10 nM) and human prostate cancer DU145 cells (IC50 = 2.5 µM) 10 mg 14833-10
AG-1024 A selective inhibitor of IGF-1R that inhibits insulin-stimulated cellular proliferation and IGF-1R autophosphorylation with IC50 values of 0.4 and 7 µM, respectively; inhibits proliferation of human breast cancer MCF-7 cells (10 nM) and human prostate cancer DU145 cells (IC50 = 2.5 µM) 5 mg 14833-5
AG-126 A tyrphostin that is a poor inhibitor of EGFRK (IC50 = 450 µM) and PDGFRK (IC50 > 100 µM) which has been found to inhibit the phosphorylation of ERK1 and ERK2 at 25-50 µM; blocks the production of TNF-alpha, attenuating signaling through NF-kappaB, the induced expression of COX-2 and iNOS, and the inflammatory response 1 mg 13297-1
AG-126 A tyrphostin that is a poor inhibitor of EGFRK (IC50 = 450 µM) and PDGFRK (IC50 > 100 µM) which has been found to inhibit the phosphorylation of ERK1 and ERK2 at 25-50 µM; blocks the production of TNF-alpha, attenuating signaling through NF-kappaB, the induced expression of COX-2 and iNOS, and the inflammatory response 10 mg 13297-10
AG-126 A tyrphostin that is a poor inhibitor of EGFRK (IC50 = 450 µM) and PDGFRK (IC50 > 100 µM) which has been found to inhibit the phosphorylation of ERK1 and ERK2 at 25-50 µM; blocks the production of TNF-alpha, attenuating signaling through NF-kappaB, the induced expression of COX-2 and iNOS, and the inflammatory response 25 mg 13297-25
AG-126 A tyrphostin that is a poor inhibitor of EGFRK (IC50 = 450 µM) and PDGFRK (IC50 > 100 µM) which has been found to inhibit the phosphorylation of ERK1 and ERK2 at 25-50 µM; blocks the production of TNF-alpha, attenuating signaling through NF-kappaB, the induced expression of COX-2 and iNOS, and the inflammatory response 5 mg 13297-5
AG-1295 A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGF receptor kinase in vitro and in Swiss 3T3 cells (IC50s range from 0.3-1 µM); inhibits PDGF-stimulated DNA synthesis (IC50 = 2.5 µM) without affecting activity of the EGF receptor 1 mg 14529-1
AG-1295 A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGF receptor kinase in vitro and in Swiss 3T3 cells (IC50s range from 0.3-1 µM); inhibits PDGF-stimulated DNA synthesis (IC50 = 2.5 µM) without affecting activity of the EGF receptor 10 mg 14529-10
AG-1295 A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGF receptor kinase in vitro and in Swiss 3T3 cells (IC50s range from 0.3-1 µM); inhibits PDGF-stimulated DNA synthesis (IC50 = 2.5 µM) without affecting activity of the EGF receptor 25 mg 14529-25
AG-1295 A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGF receptor kinase in vitro and in Swiss 3T3 cells (IC50s range from 0.3-1 µM); inhibits PDGF-stimulated DNA synthesis (IC50 = 2.5 µM) without affecting activity of the EGF receptor 5 mg 14529-5
AG-1296 A potent and selective inhibitor of PDGF receptor kinase with an IC50 value of about 0.4 µM both in vitro and in cells (Swiss 3T3 cells) 1 mg 10010592-1
AG-1296 A potent and selective inhibitor of PDGF receptor kinase with an IC50 value of about 0.4 µM both in vitro and in cells (Swiss 3T3 cells) 10 mg 10010592-10
AG-1296 A potent and selective inhibitor of PDGF receptor kinase with an IC50 value of about 0.4 µM both in vitro and in cells (Swiss 3T3 cells) 25 mg 10010592-25
AG-1296 A potent and selective inhibitor of PDGF receptor kinase with an IC50 value of about 0.4 µM both in vitro and in cells (Swiss 3T3 cells) 5 mg 10010592-5
AG-1478 An inhibitor of EGFR kinase with an IC50 value of 3 nM 25 mg 10010244-25
AG-1478 An inhibitor of EGFR kinase with an IC50 value of 3 nM 5 mg 10010244-5
AG-1478 An inhibitor of EGFR kinase with an IC50 value of 3 nM 1 mg 10010244-1
AG-1478 An inhibitor of EGFR kinase with an IC50 value of 3 nM 10 mg 10010244-10
© 1980 - 2014 Linscott's Directory, Linscott's USA. All rights reserved.